Table 4 Prevalence of strains carrying a Difficult-to-treat Resistance (DTR) phenotype isolated in Provence-Alpes-Côte d’Azur from January 2014 to February 2019 and comparison with the study of Kadri et al.
Bacterial strains | Number of DTR (number of strains) | Rate (%) | 173 hospitals in USA (Kadri et al.4) |
|---|---|---|---|
Escherichia coli | 85 (246, 353) | 0.03 | 12/28,640 (0.04) |
Klebsiella spp. (K. pneumoniae and K. oxytoca | 383 (57,620) | 0.66 | 155/9168 (1.7) |
Enterobacter spp. (K. aerogenes* and E. cloacae) | 39 (21,602) | 0.18 | 20/3221 (0.6) |
Proteus mirabilis | 1 (18,064) | 0.006 | NA |
Serratia marcescens | 3 (4437) | 0.07 | NA |
Morganella morganii | 5(4935) | 0.1 | NA |
Pseudomonas aeruginosa | 902 (34,966) | 2.6 | 101/4493 (2.3) |
Acinetobacter baumannii | 175 (1098) | 15.9 | 183/999 (18.3) |
Enterococcus faecalis | 3 (36,857) | 0.008 | NA |
Enterococcus faecium | 5 (4871) | 0.10 | NA |
Staphylococcus aureus | 0 (65,023) | 0 | NA |
Staphylococcus epidermidis | 3 (28,527) | 0.01 | NA |
Streptococcus agalactiae | 0 (14,684) | 0 | NA |
Total (comparison with Kadri et al.) | 1584 (361,639) | 0.44 | 1.01 (471/46,521) |
Total | 1604 (539,037) | 0.3 | NA |